Progress in Targeted Nanotherapeutic Delivery Systems for Cancer Precision Medicine
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 15
Special Issue Editors
Interests: developing magnetic nanotechnology-based cancer therapies
Special Issue Information
Dear Colleagues,
Cancer remains one of the leading causes of death globally, compelling substantial investments in understanding tumor mechanisms and urging advancements in precision medicine. Still, the current therapy landscape is compounded with evolving tumor heterogeneity, complex tumor microenvironment, drug resistance, limitations of passive targeting, subpar pharmacokinetics, drug instability, and systemic toxicity. While newer inhibitors, RNAi drugs, and immunotherapy targets have provided strategic therapeutic solutions, effective transport of therapeutic molecules to the intended tumor site remains a major challenge in precision cancer therapy. Therefore, there is a clinical need to develop and explore innovative solutions to cancer drug delivery.
Pioneering initiatives to overcome the challenge have involved the use of healthcare-related nanomaterials. Such materials show great promise and potential in developing effective drug carriers that exhibit efficient and stable drug formulations, active targeting, unique theranostic properties, enhanced tumor penetration, reduced toxicity, and improved therapeutic efficacy. However, the successful development, scaling, and clinical translatability of nanomedicines have been lagging and difficult, warranting scientific innovation to address the critical gap. Thus, this Special Issue is dedicated to promoting and catalyzing efforts to drive scientific progress and breakthroughs in nanotechnology-mediated drug delivery strategies in cancer therapy. Importantly, this issue will rigorously focus on the synthesis rationale, nanomedicine’s biocompatibility, scalability, and reproducibility, efficiency in selective targeting and drug delivery, tumor penetration (in 3D tumoroids and animals), and therapeutic efficacy.
We invite investigators to contribute their original research articles or reviews that provide new insights into nanomaterial phenomena, synthesis, and its translation towards effective cancer drug delivery and personalized cancer therapy.
Dr. Linlin Zhang
Dr. Dhananjay Suresh
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer therapy
- drug delivery
- tumor targeting
- nanotechnology
- precision medicine
- immunotherapy
- new approach methodologies (NAMs)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
